Literature DB >> 5545134

Synthesis of the second component of guinea pig complement in vitro.

D J Rubin, T Borsos, H J Rapp, H R Colten.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5545134

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  7 in total

1.  Differences between plasma and serum complement in patients with chronic liver disease.

Authors:  S Inai; H Kitamura; T Fujita; J Kojima; K Nagaki
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

2.  C3 activation by a new factor B-dependent enzyme detected in culture supernatant from guinea-pig peritoneal macrophages.

Authors:  H U Beuscher; V Brade
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

3.  Ontogeny of the human complement system: in vitro biosynthesis of individual complement components by fetal tissues.

Authors:  H R Colten
Journal:  J Clin Invest       Date:  1972-04       Impact factor: 14.808

4.  Serum complement level in workers exposed to nebzene, toluene and xylene.

Authors:  R Smolik; K Grzybek-Hryncewicz; A Lange; W Zatoński
Journal:  Int Arch Arbeitsmed       Date:  1973-07-10

5.  Biosynthesis of the second (C2) and fourth (C4) components of complement in vitro by tissues isolated from guinea-pigs with genetically determined C4 deficiency.

Authors:  H R Colten; M M Frank
Journal:  Immunology       Date:  1972-06       Impact factor: 7.397

6.  Effect of cycloheximide and of anti-C3 Fab' on the intrinsic synthesis and secretion of lysosomal enzyme and of complement components by guinea-pig peritoneal macrophages.

Authors:  G Kreuzpaintner; V Brade
Journal:  Immunology       Date:  1983-06       Impact factor: 7.397

7.  Synthesis of the second component of complement by long-term primary cultures of human monocytes.

Authors:  L P Einstein; E E Schneeberger; H R Colten
Journal:  J Exp Med       Date:  1976-01-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.